Antidote competitorsClear all
Antidote's top competitors include Durect, Amarin, Zogenix and BTG.
| Save Comparison |  Antidote Antidote is accelerating the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Amarin Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | |
Founding Date | Founding Date 2009 | Founding Date N/A | Founding Date 1991 | Founding Date 2006 | Founding Date 1948 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations London, GB HQ Carmel, US New York, US | Locations Cupertino, US HQ | Locations Dublin 2, IE HQ Dublin, IE Bridgewater Township, US | Locations Emeryville, US HQ Windsor And Maidenhead, GB | |
Employees | Employees 552% increase | Employees 902% increase | Employees 96582% increase | Employees 14157% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 521.4 m | Valuation ($) 2.6 b | Valuation ($) 1.7 b | Valuation ($) N/A |
Twitter followers | Twitter followers 1 | Twitter followers N/A | Twitter followers N/A | Twitter followers 638 | Twitter followers 1.1 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) 2 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 8.3 | Average likes per tweet (last 30 days) 4.5 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Alexa Website Rank | Alexa Website Rank 230742 | Alexa Website Rank 160807 | Alexa Website Rank 233381 | Alexa Website Rank 421122 | Alexa Website Rank 239711 |
Financial | |||||
Revenue (est.) | Revenue (est.) £1.5m (FY, 2018) | Revenue (est.) $29.6m (FY, 2019) | Revenue (est.) $429.8m (FY, 2019) | Revenue (est.) $3.6m (FY, 2019) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods £1.1m (FY, 2018) | Cost of goods $4.1m (FY, 2019) | Cost of goods $96m (FY, 2019) | Cost of goods N/A | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit £447.6k (FY, 2018) | Gross profit $25.4m (FY, 2019) | Gross profit $333.7m (FY, 2019) | Gross profit $3.6m (FY, 2019) | Gross profit £510.3m (FY, 2019) |
Net income | Net income (£5.3m) (FY, 2018) | Net income ($20.6m) (FY, 2019) | Net income ($22.6m) (FY, 2019) | Net income ($419.5m) (FY, 2019) | Net income £88.3m (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 17.9m | Total funding raised $ 20m | Total funding raised $ 70m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View company profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companyAmarin
HQ
Dublin 2, IE
Employees
965
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease.
View companyZogenix
HQ
Emeryville, US
Employees
141
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company